Back
Guggenheim Strategic Opportunities Fund Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
65
GOF
Guggenheim Strategic Opportunities Fund
Last Price:
$12.51
Seasonality Move:
0.55%
Buy
60
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.61
Seasonality Move:
-4.31%
Buy
65
Guggenheim Strategic Opportunities Fund (GOF)
is a Buy
Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?
-
The current Guggenheim Strategic Opportunities Fund [GOF] share price is $12.51. The Score for GOF is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
GOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.69. The Score for GPCR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GOF Stock Price Chart
What is Guggenheim Strategic Opportunities Fund's stock price today?
-
The Guggenheim Strategic Opportunities Fund share price today is $12.51The current trend is relatively stagnant and GOF is experiencing slight buying pressure.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.
GOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 55.13 | Buy |
| Chaikin Money Flow: | 720212 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.02 - 12.32) | Buy |
| Bollinger Bands (100): | (12.67 - 15.09) | Sell |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.55 | Buy |
| Relative Strength Index (14 RSI): | 70.17 | Buy |
| Chaikin Money Flow: | -284110 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.64 - 66.86) | Buy |
| Bollinger Bands (100): | (17.09 - 46.21) | Buy |
GOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.2 | Buy |
| 20-day SMA: | 12.2 | Buy |
| 50-day SMA: | 12.79 | Sell |
| 200-day SMA: | 14.36 | Sell |
| 8-day EMA: | 12.24 | Buy |
| 20-day EMA: | 12.28 | Buy |
| 50-day EMA: | 12.81 | Sell |
| 200-day EMA: | 14.09 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.76 | Buy |
| 20-day SMA: | 54.7 | Buy |
| 50-day SMA: | 41.07 | Buy |
| 200-day SMA: | 26.34 | Buy |
| 8-day EMA: | 65.27 | Buy |
| 20-day EMA: | 57.2 | Buy |
| 50-day EMA: | 45.22 | Buy |
| 200-day EMA: | 31.64 | Buy |
Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
Guggenheim Strategic Opportunities Fund Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||